The panel performed well in detecting early-stage and AFP-negative HCC, as well as differentiating HCC in hepatitis B infection (CHB), liver cirrhosis (LC), and benign hepatic lesions (BHL) 42. Here, AFP is linked to hepatocellular carcinoma.